Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

pDNA bioparticles: comparative heterogeneity, surface, binding, and activity analyses.

P Medberry1, S Dennis, T Van Hecke

  • 1Abgenix, Fremont, CA 94555, USA.

Biochemical and Biophysical Research Communications
|June 5, 2004
PubMed
Summary

Novel protamine and chitosan DNA nanoparticles show promise as safe and effective alternatives to viral or liposomal delivery systems for nucleic acid therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time fluorometric isothermal assays for detection of Streptococcus equi subspecies equi and Streptococcus equi subspecies zooepidemicus in horses: Validation, comparison and evaluation of their clinical application.

Australian veterinary journal·2025
Same author

Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.

The European physical journal. C, Particles and fields·2022
Same author

Demonstrating the processes and outcomes of a rural Community Mental Health Rehabilitation Service: A realist evaluation.

PloS one·2021
Same author

Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.

The European physical journal. C, Particles and fields·2021
Same author

Core surgical field camps: a new deanery-based model for enhancing advanced skills in core surgical trainees through simulation.

British journal of hospital medicine (London, England : 2005)·2020
Same author

Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer.

The Journal of pharmacology and experimental therapeutics·2019

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Molecular Biology

Background:

  • Nucleic acid-bound micro/nanoparticles are gaining traction in diverse applications like drug delivery and diagnostics.
  • Current viral and liposomal technologies face limitations including heterogeneity, aggregation, immunotoxicity, and poor physiological fluid compatibility.

Purpose of the Study:

  • To investigate novel plasmid DNA (pDNA) bioparticles formed by complexation with various non-viral/non-lipid materials.
  • To evaluate these pDNA bioparticles for their stability, protein binding, transfection efficiency, and immunotoxicity.

Main Methods:

  • Systematic characterization of pDNA bioparticles formed with materials such as polybrene, chitosan, protamine, and peptides.
  • Assessment of particle properties including heterogeneity, kinetics, partitioning, protein binding, surface characteristics, size, and electrophoretic behavior.

Related Experiment Videos

  • Evaluation of transfection efficacy and immunotoxicity in relevant biological models.

    • Main Results:

    • Protamine and chitosan DNA particles demonstrated extended stability (12-18h) and low protein binding (<10 µg/ml).
    • These particles exhibited good transfection activity (10^2–10^4 RLU/mg cell protein) and low immunotoxicity.
    • Other tested materials showed varying degrees of success but did not match the performance of protamine and chitosan.

    Conclusions:

    • Protamine and chitosan are promising materials for developing pDNA bioparticles as alternatives to viral or liposomal vectors.
    • These novel bioparticles offer potential for nucleic acid-based therapeutics, expression systems, and binding agents.
    • Further research is warranted to explore the full therapeutic potential of these pDNA bioparticles.